131 related articles for article (PubMed ID: 37154079)
1. Upregulation of MAPKAPK5-AS1, PXN-AS1 and URB1-AS1 lncRNAs in non-functioning pituitary adenoma.
Taheri M; Safarzadeh A; Bahranian A; Eslami S; Dilmaghani NA; Ghafouri-Fard S; Sharifi G
J Cell Mol Med; 2023 Jun; 27(11):1550-1556. PubMed ID: 37154079
[TBL] [Abstract][Full Text] [Related]
2. Expression of cAMP and oxidative phosphorylation-related lncRNAs in non-functioning pituitary adenomas.
Taheri M; Nicknam A; Bagan A; Eslami S; Rakhshan A; Ghafouri-Fard S
J Cell Mol Med; 2023 Dec; 27(24):4195-4201. PubMed ID: 37933082
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Khaledabadi M; Najafi G; Safarzadeh A; Hussen BM; Eslami S; Sharifi G; Taheri M; Dilmaghani NA
Pathol Res Pract; 2023 Aug; 248():154668. PubMed ID: 37418994
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.
Jia X; Niu P; Xie C; Liu H
Cancer Med; 2019 Aug; 8(9):4278-4291. PubMed ID: 31173488
[TBL] [Abstract][Full Text] [Related]
5. Up‑regulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma.
Shang F; Du SW; Ma XL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8950-8955. PubMed ID: 31696482
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
[TBL] [Abstract][Full Text] [Related]
7. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.
Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X
J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
9. IncRNA MAPKAPK5-AS1 promotes proliferation and migration of thyroid cancer cell lines by targeting miR-519e-5p/YWHAH.
Zhou Y; Liu S; Luo Y; Zhang M; Jiang X; Xiong Y
Eur J Histochem; 2020 Dec; 64(4):. PubMed ID: 33272009
[TBL] [Abstract][Full Text] [Related]
10. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
Peng Z; Ouyang X; Wang Y; Fan Q
BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
12. High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2.
Miao J; Gao Y; Guan W; Yu X; Wang Y; Jiang P; Yang L; Xu L; You W
Genes Genomics; 2023 May; 45(5):611-625. PubMed ID: 36445573
[TBL] [Abstract][Full Text] [Related]
13. Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior.
Li Z; Li C; Liu C; Yu S; Zhang Y
Pituitary; 2015 Feb; 18(1):42-7. PubMed ID: 24469926
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of autophagy-related long non-coding RNAs in Iranian patients with breast cancer.
Safarzadeh A; Akhavan-Bahabadi M; Hussen BM; Nicknam A; Eslami S; Pouresmaeili F; Ghafouri-Fard S; Taheri M
Pathol Res Pract; 2022 Nov; 239():154146. PubMed ID: 36195025
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.
Yu G; Li C; Xie W; Wang Z; Gao H; Cao L; Hao L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1140-1148. PubMed ID: 28656268
[TBL] [Abstract][Full Text] [Related]
16. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.
Yuan JH; Liu XN; Wang TT; Pan W; Tao QF; Zhou WP; Wang F; Sun SH
Nat Cell Biol; 2017 Jul; 19(7):820-832. PubMed ID: 28553938
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA PXN-AS1-L promotes non-small cell lung cancer progression via regulating PXN.
Zhang Z; Peng Z; Cao J; Wang J; Hao Y; Song K; Wang Y; Hu W; Zhang X
Cancer Cell Int; 2019; 19():20. PubMed ID: 30679933
[TBL] [Abstract][Full Text] [Related]
18. Identification of lung-adenocarcinoma-related long non-coding RNAs by random walking on a competing endogenous RNA network.
Zhang H; Wang Y; Lu J
Ann Transl Med; 2019 Jul; 7(14):339. PubMed ID: 31475209
[TBL] [Abstract][Full Text] [Related]
19. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
